A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

A Phase 2 Randomized Pilot Study Comparing High-Dose-Rate Brachytherapy and Low-Dose-Rate Brachytherapy as Monotherapy in Localized Prostate Cancer

Purpose: To compare health-related quality of life (HRQOL) of high-dose-rate brachytherapy (HDRB) versus low dose-rate brachytherapy (LDRB) for localized prostate cancer in a multi-institutional phase 2 randomized trial. Methods and Materials: Men with favorable-risk prostate cancer were randomized...

Full description

Bibliographic Details
Main Authors: Lara Hathout, MD, FRCPC, Omar Mahmoud, MD, PhD, Yaqun Wang, PhD, Irina Vergalasova, PhD, Maroie Barkati, MD, FRCPC, Philippe Després, PhD, André-Guy Martin, MD, MSc, FRCPC, William Foster, MD, FRCPC, Frédéric Lacroix, PhD, Guila Delouya, MD, MSc, FRCPC, Daniel Taussky, MD, FRCPC, Gerard Morton, MD, FRCPC, Eric Vigneault, MD, MSc, FRCPC
Format: Article
Language:English
Published: Elsevier 2019-10-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2452109419300491

Internet

http://www.sciencedirect.com/science/article/pii/S2452109419300491

Similar Items